POSSIBLE EFFICACY OF HYDROXYCHLOROQUINE ON ACCELERATED NODULOSIS DURING MTX THERAPY FOR RA - REPLY

被引：0
|
作者：
KERSTENS, PJSM
BOERBOOMS, AMT
VANDEPUTTE, LBA
机构：
来源：
JOURNAL OF RHEUMATOLOGY | 1993年 / 20卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 43 条
  • [21] EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RA NAIVE TO MTX THERAPY: FINCH3 PRIMARY OUTCOME RESULTS
    McKay, Neil
    van der Heijde, Desiree
    Westhovens, Rene
    Rigby, William F. C.
    Ching, Daniel W. T.
    Bartok, Beatrix
    Matzkies, Franziska
    Yin, Zhaoyu
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Mozaffarian, Neelufar
    Messina, Osvaldo D.
    Landewe, Robert B. M.
    Atsumi, Tatsuya
    Burmester, Gerd R.
    [J]. RHEUMATOLOGY, 2020, 59
  • [22] TOLERANCE AND EFFICACY OF METHOTREXATE (MTX) AS FIRST DISEASE-MODIFYING AGENT DURING RHEUMATOID-ARTHRITIS (RA)
    BOLOGNA, C
    VIU, P
    JORGENSEN, C
    SANY, J
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1451 - 1451
  • [23] Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy
    De Stefano, R.
    Frati, E.
    Nargi, F.
    Menza, L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 752 - 753
  • [24] Methotrexate (M) sulfasalazine (S) hydroxychloroquine (H) combination therapy in ra patients: Efficacy and toxicity at 3 years.
    ODell, J
    Haire, C
    Drymalski, W
    Palmer, W
    Eckhoff, PJ
    Maloley, P
    Klassen, L
    Wees, S
    Klein, H
    Moore, G
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : R12 - R12
  • [25] Possible mechanisms for ischemic colitis during alosetron therapy - Reply
    Friedel, D
    Fisher, RS
    [J]. GASTROENTEROLOGY, 2001, 121 (01) : 232 - 232
  • [26] IN REPLY TO 'A POSSIBLE MECHANISM FOR SEVERE SYMPTOMATIC HYPONATREMIA DURING SIBUTRAMINE THERAPY'
    Esposito, Pasquale
    Rampino, Teresa
    Dal Canton, Antonio
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2008, 52 (06) : 1198 - 1198
  • [27] Efficacy of treatment with the IL-6R inhibitor tocilizumab (TCZ) in patients with active RA despite MTX therapy: The option study
    Beaulieu, Andre D.
    Rubbert-Roth, A.
    Woodworth, T.
    Alecock, E.
    Alten, R.
    Laughton, J.
    Eves, D.
    Smolen, J.
    [J]. RHEUMATOLOGY, 2008, 47 : II15 - II16
  • [28] Loss of antidepressant efficacy during maintenance therapy: Possible mechanisms and treatments
    Byrne, SE
    Rothschild, AJ
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (06) : 279 - 288
  • [29] SOLUBLE CD4 AND CD8 LEVELS IN REFRACTORY RA - CORRELATIONS WITH DISEASE-ACTIVITY DURING MTX THERAPY
    DOOLEY, MA
    PISETSKY, DS
    DAWSON, DV
    POLISSON, RP
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S144 - S144
  • [30] In early RA, patients with a good initial response to MTX monotherapy continue to have excellent clinical outcomes during the first year of therapy
    Van Vollenhoven, Ronald F.
    Ernestam, Sofia
    Geborek, Pierre
    Petersson, Ingemar F.
    Coster, Lars
    Waltbrand, Eva
    Zickert, Agneta
    Theander, Jan
    Thorner, Ake
    Hellstrom, Helena
    Teleman, Annika
    Dackhammar, Christina
    Akre, Finn
    Forslind, Kristina
    Ljung, Lotta
    Oding, Rolf
    Wornert, Margareta
    Bratt, Johan
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S432 - S432
12345